Correlation Between Immunome and Icosavax
Can any of the company-specific risk be diversified away by investing in both Immunome and Icosavax at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Immunome and Icosavax into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Immunome and Icosavax, you can compare the effects of market volatilities on Immunome and Icosavax and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Immunome with a short position of Icosavax. Check out your portfolio center. Please also check ongoing floating volatility patterns of Immunome and Icosavax.
Diversification Opportunities for Immunome and Icosavax
Excellent diversification
The 3 months correlation between Immunome and Icosavax is -0.69. Overlapping area represents the amount of risk that can be diversified away by holding Immunome and Icosavax in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Icosavax and Immunome is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Immunome are associated (or correlated) with Icosavax. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Icosavax has no effect on the direction of Immunome i.e., Immunome and Icosavax go up and down completely randomly.
Pair Corralation between Immunome and Icosavax
Given the investment horizon of 90 days Immunome is expected to generate 1.01 times more return on investment than Icosavax. However, Immunome is 1.01 times more volatile than Icosavax. It trades about 0.08 of its potential returns per unit of risk. Icosavax is currently generating about -0.01 per unit of risk. If you would invest 484.00 in Immunome on August 31, 2024 and sell it today you would earn a total of 871.00 from holding Immunome or generate 179.96% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 8.56% |
| Values | Daily Returns |
Immunome vs. Icosavax
Performance |
| Timeline |
| Immunome |
| Icosavax |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Immunome and Icosavax Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Immunome and Icosavax
The main advantage of trading using opposite Immunome and Icosavax positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Immunome position performs unexpectedly, Icosavax can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Icosavax will offset losses from the drop in Icosavax's long position.| Immunome vs. Anebulo Pharmaceuticals | Immunome vs. Adagene | Immunome vs. Acrivon Therapeutics, Common | Immunome vs. AnaptysBio |
| Icosavax vs. Terns Pharmaceuticals | Icosavax vs. Amylyx Pharmaceuticals | Icosavax vs. Acumen Pharmaceuticals | Icosavax vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Other Complementary Tools
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |